Skip to main content
GENFIT logo

GENFIT — Investor Relations & Filings

Ticker · GNFT ISIN · FR0004163111 LEI · 969500XPWN2DMZQA5X73 PA Professional, scientific and technical activities
Open in API
Filings indexed 681 across all filing types
Latest filing 2019-09-09 Board/Management Inform…
Country FR France
Listing PA GNFT

About GENFIT

https://www.genfit.com

GENFIT is a biopharmaceutical company dedicated to developing therapeutic and diagnostic solutions for patients with rare and severe liver diseases characterized by high unmet medical needs. The company's primary focus is on Acute-on-Chronic Liver Failure (ACLF) and its associated conditions, such as acute decompensation (AD) and hepatic encephalopathy (HE). Leveraging a scientific heritage of over two decades, GENFIT is a pioneer in liver disease research and development, aiming to improve the lives of patients with these life-threatening conditions.

Recent filings

Filing Released Lang Actions
Genfit: GENFIT: Le Docteur Carol L. Addy nommée au poste de Directrice Médicale
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Chief Medical Officer (Dr. Carol L. Addy) at GENFIT. It includes biographical information, quotes from the new appointee and the CEO, and a summary of the company's clinical development pipeline. This type of announcement regarding senior management changes falls under the 'Board/Management Information' category. While it contains a link to a 'Pièce jointe' (attachment), the document itself is a full press release detailing the news, not merely a notification of a report's publication.
2019-09-09 French
Genfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Chief Medical Officer (Dr. Carol L. Addy) at GENFIT. It includes biographical information, quotes from the new hire and the CEO, and an overview of the company's clinical pipeline. While it contains corporate information, it does not fit into specific financial reporting categories like 10-K or IR. It is a standard corporate announcement regarding management changes and operational updates, which falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2019-09-09 English
Genfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Chief Medical Officer (Dr. Carol L. Addy) at GENFIT. It includes biographical information, quotes from the new hire and the CEO, and an overview of the company's clinical pipeline. While it contains corporate information, it does not fit into specific financial reporting categories like 10-K or IR. It is a standard corporate announcement regarding management changes and operational updates, which falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2019-09-09 English
Genfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Chief Medical Officer (Dr. Carol L. Addy) at GENFIT. It includes biographical information, quotes from the new hire and the CEO, and an overview of the company's clinical pipeline. While it contains corporate information, it does not fit into specific financial reporting categories like 10-K or IR. It is a standard corporate announcement regarding management changes and operational updates, which falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2019-09-09 English
Genfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Chief Medical Officer (Dr. Carol L. Addy) at GENFIT. It includes biographical information, quotes from the new hire and the CEO, and an overview of the company's clinical pipeline. While it contains corporate information, it does not fit into specific financial reporting categories like 10-K or IR. It is a standard corporate announcement regarding management changes and operational updates, which falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2019-09-09 English
Genfit: GENFIT: Le Docteur Carol L. Addy nommée au poste de Directrice Médicale
Board/Management Information Classification · 99% confidence The document is a press release dated September 9, 2019, announcing that Dr. Carol L. Addy has been appointed as the Chief Medical Officer (Directrice Médicale) of GENFIT. This announcement concerns a change in senior management/board personnel. Reviewing the definitions, the category 'Board/Management Information (Code: MANG)' specifically covers 'Announcement of changes in the company's board of directors or senior management.' The content perfectly matches this description. The document is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A).
2019-09-09 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.